VISEN Pharmaceuticals (02561.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.3x

Market Cap

HKD 2.04B

MomentumView details →

1D Return

+2.39%

YTD Return

−40.00%

RSI (14)

47.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−5.3x

Market Cap

HKD 2.04B

RSI (14)

47.0

MomentumView details →

1D Return

+2.39%

YTD Return

−40.00%

ProfitabilityView details →

Gross Margin

105.81%

Net Margin

—

EBITDA Margin

9629.06%

ROE (TTM)

−33.26%

ROA (TTM)

−25.93%

Asset Turnover

−0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−26.42%

FCF YoY

—

Revenue CAGR 3Y

−94.21%

EPS CAGR 3Y

−22.05%

EBITDA YoY

−42.33%

EarningsView details →

EPS (Actual)

−HKD 1.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

4.47x

Quick Ratio

4.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

−2.51M

Net Income (TTM)

−253.42M

Op. CF (TTM)

−447.58M

Next earningsApr 1, 2027 →

Latest newsMore news →

No recent news for 02561.HK.

Similar companies

Perrigo Company plcPRGO Jacobson Pharma Corporation Limited02633.HK Avadel Pharmaceuticals plcAVDL AlvotechALVO Chia Tai Enterprises International Limited03839.HK Dynavax Technologies CorporationDVAX Find similar companies →

Latest newsMore news →

No recent news for 02561.HK.